Thursday, 25 April 2013

Czech Republic Pharmaceuticals and Healthcare Report Q2 2013

Business Monitor International Market Research Reports
Market Reports Online XML Feed
Czech Republic Pharmaceuticals and Healthcare Report Q2 2013
Apr 24th 2013, 00:00

BMI View: The Czech pharmaceutical market is the most developed in terms of spending and ease ofoperation in the Central and Eastern European region, but it continues to present challenges fordrugmakers. Price erosion by regulatory agencies and blind bidding auctions drive prices down year-onyear.The open movement of goods and services in the European Union has given rise to an arbitrageopportunity for medicines, which certain businesses have exploited. While within the letter of the law, theimpact of parallel exports is felt by patients, who have reported shortages of vital medicines. Thisworrying trend is being seen across Central and Eastern Europe. We highlight th...

Delicious Digg Evernote Facebook Google Bookmarks Google Plus LinkedIn StumbleUpon Tumblr Twitter
You are receiving this email because you subscribed to this feed at

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment